COVID-19: Drug Discovery and Repurposing
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, prompted researchers from government agencies and the private sector to look for potential medicines to reduce or eliminate the symptoms of the disease. To accelerate the discovery of an effective drug, both the drug repurposing strategy and the identification of new SARS-CoV-2 proteins were widely used. Computational […]
